Terms of reference

Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer, with particular reference to:

(a)barriers to screening and diagnosis, including the impact of factors such as:

(i)geographic location,

(ii)cost,

(iii)cultural and language barriers,

(iv)type of cancer, and

(v)availability of treating practitioners;

(b)barriers to accessing appropriate treatment;

(c)the adequacy of support services after diagnosis;

(d)the adequacy of Commonwealth funding for research into rare, less common and neuroendocrine cancer; and

(e)any other related matters.